Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385060![]() (US10287267, Compound 69 | US10508099, Compound 69 ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.70E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385064![]() (US10287267, Compound 71 | US10508099, Compound 71 ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.90E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385054![]() (US10287267, Compound 14 | US10508099, Compound 14 ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 354 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385041![]() (US10287267, Compound 1 | US10508099, Compound 1 | ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 650 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385042![]() (US10287267, Compound 3 | US10508099, Compound 3 | ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM422047![]() (US10508099, Compound 4 | US10556885, Compound 4 | ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 983 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385045![]() (US10287267, Compound 6 | US10508099, Compound 6 | ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385046![]() (US10287267, Compound 10 | US10508099, Compound 10 ...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 277 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385364![]() (US10287267, Compound 1074 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385365![]() (US10287267, Compound 1075 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.54E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385366![]() (US10287267, Compound 1076 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 640 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385367![]() (US10287267, Compound 1077 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.19E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385368![]() (US10287267, Compound 1078 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.03E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385369![]() (US10287267, Compound 1079 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385370![]() (US10287267, Compound 1080 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385167![]() (US10287267, Compound 327 | US10508099, Compound 10...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.73E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385372![]() (US10287267, Compound 1082 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.90E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385373![]() (US10287267, Compound 1083 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.21E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM422353![]() (US10508099, Compound 1084 | US10556885, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.41E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385067![]() (US10287267, Compound 1085 | US10287267, Compound 7...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385079![]() (US10287267, Compound 1086 | US10287267, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 485 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385079![]() (US10287267, Compound 1086 | US10287267, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 514 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385378![]() (US10287267, Compound 1088 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385379![]() (US10287267, Compound 1090 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 722 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM422359![]() (US10508099, Compound 1091 | US10556885, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.95E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385381![]() (US10287267, Compound 1092 | US10508099, Compound 1...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 247 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proto-oncogene Wnt-1 (Homo sapiens (human)) | BDBM385128![]() (US10287267, Compound 284 | US10287267, Compound 30...) | UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.78E+3 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description SW480 colon carcinoma cells were transduced with a lentiviral vector expressing luciferase with a human Sp5 promoter consisting of a sequence of eigh... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385041![]() (US10287267, Compound 1 | US10508099, Compound 1 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385042![]() (US10287267, Compound 3 | US10508099, Compound 3 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM422047![]() (US10508099, Compound 4 | US10556885, Compound 4 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385045![]() (US10287267, Compound 6 | US10508099, Compound 6 | ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385046![]() (US10287267, Compound 10 | US10508099, Compound 10 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385054![]() (US10287267, Compound 14 | US10508099, Compound 14 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385056![]() (US10287267, Compound 16 | US10508099, Compound 16 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385060![]() (US10287267, Compound 69 | US10508099, Compound 69 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385064![]() (US10287267, Compound 71 | US10508099, Compound 71 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13.6 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385067![]() (US10287267, Compound 1085 | US10287267, Compound 7...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385069![]() (US10287267, Compound 73 | US10508099, Compound 73 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385073![]() (US10287267, Compound 75 | US10508099, Compound 75 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385078![]() (US10287267, Compound 76 | US10508099, Compound 76 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385079![]() (US10287267, Compound 1086 | US10287267, Compound 1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385080![]() (US10287267, Compound 78 | US10508099, Compound 78 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385081![]() (US10287267, Compound 81 | US10508099, Compound 81 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385082![]() (US10287267, Compound 304 | US10287267, Compound 82...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385083![]() (US10287267, Compound 83 | US10508099, Compound 83 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385084![]() (US10287267, Compound 84 | US10508099, Compound 84 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385085![]() (US10287267, Compound 85 | US10508099, Compound 85 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385086![]() (US10287267, Compound 86 | US10508099, Compound 86 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385087![]() (US10287267, Compound 87 | US10508099, Compound 87 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Homo sapiens (Human)) | BDBM385088![]() (US10287267, Compound 89 | US10508099, Compound 89 ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a |
Samumed, LLC US Patent | Assay Description Each compound was dissolved in DMSO as a 10 mM stock and used to prepare compound source plates. Serial dilution (1:3, 11-point dose-response curves ... | US Patent US10508099 (2019) BindingDB Entry DOI: 10.7270/Q2DJ5J0C | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 951 total ) | Next | Last >> |